KIT and lymphoma: Although there are few reports on the use of toceranib for the treatment of lymphoma in dogs, Yamazaki et al. [27] reported that the c-kit expression rate was higher in T-cells than in B-cells in a study of five dogs with multidrug-resistant lymphomas.